Xcell Therapeutics Inc. (KOSDAQ:373110)
1,415.00
+64.00 (4.74%)
Mar 10, 2026, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 23.36 billion as of March 9, 2026. Its market cap has decreased by -53.05% in one year.
Market Cap
23.36B
Enterprise Value
28.51B
Revenue
1.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,415.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 23.36B, a decrease of -74.10%. That is a compound annual growth rate of -55.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 23.36B | -18.66% |
| Dec 30, 2025 | 28.73B | -35.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ORIENT BIO | 68.89B |
| Oncocross | 85.15B |
| GeneOne Life Science | 92.36B |
| Amicogen | 94.41B |
| IMB Dx | 96.02B |
| CG Invites | 111.96B |
| MedPacto | 174.46B |
| ENCell | 177.52B |